Iceland· IS-EU/1/21/1596/001
TEPMETKO
A tepotinib product containing tepotinibum inn, registered in Iceland by Merck Europe B.V.*. The same ATC class is registered in 11 of our 19 countries.
Checked against Icelandic Medicines Agency (Iceland) on
Informational only — not a medical device.
Where it is registered
Tepotinib is registered in 11 of 19 countries.
Countries holding a registration under ATC L01EP02 (tepotinib), each read from that country’s own register.
- This record: Iceland, from Icelandic Medicines Agency (Iceland)
- 7 of them publish a price we can compare per daily dose
Tepotinib · ATC L01EP02
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Japan
- Netherlands
- Norwayprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of tepotinib costs, country by country.
Normalised to the WHO defined daily dose (0.45 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Tepotinib · price per daily dose (0.45 g)
USD · FX 28 Sept 2026
- CH Switzerland$259.05
The record
At a glance
Icelandic Medicines Agency (Iceland)- Active substance
- Tepotinibum INN
- Manufacturer
- Merck Europe B.V.*
- Country
- Iceland (IS)
- ATC code
- L01EP02
- ATC class
- Tepotinib
- Defined daily dose
- 0.45 g, O
- Reimbursed
- Not published by this register
- Source register
- Icelandic Medicines Agency (Iceland)
- Last checked
- September 29, 2026
Packs & prices · 1
1 priced- ean99627560 stk x1 pakkiISK 834524
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tepotinib in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandTEPMETKOAbacus Medicine A/S
- SwitzerlandTepmetko 225 mg, FilmtablettenMerck (Schweiz) AG
- CzechiaTEPMETKOMerck Europe B.V., Amsterdam
- SpainTEPMETKO 225 MG COMPRIMIDOS RECUBIERTOS CON PELICULAMerck Europe B.V.
- IrelandTEPMETKO 225 mg film-coated tabletsMerck Europe B.V.
- NetherlandsTepmetko 225 mg, filmomhulde tablettenMerck Europe B.V.
- NorwayTepmetkoMerck Europe B.V.
- PolandTepmetkoMerck Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Liechtenstein · Tepmetko
- Norway · Tepmetko
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db21adc7-342a-4c07-9ea4-ff402bca600a GET /v1/drugs/db21adc7-342a-4c07-9ea4-ff402bca600a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmuhúðuð tafla",
"source": "lyfjastofnun",
"atc_raw": "L01EP02",
"marketed": false,
"strength": "225 mg",
"ma_number": "EU/1/21/1596/001",
"substance": "Tepotinibum INN",
"other_info": "Ávísun lyfsins er bundin við sérfræðinga í lungnalækningum og krabbameinslækningum.",
"legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
"ma_issued_serial": "44608"
}See everything about tepotinib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.